This article is free to access.
The proceedings contain 46 papers. The topics discussed include: methylisothiazolinone contact allergy: a real outbreak; assessment of aggregate consumer exposure to isothiazolinones via cosmetics and detergents; the clinical time-course of diphenylcyclopropenone-induced contact allergy in healthy humans following repeated epicutaneous challenges; pattern of symptoms after standardized challenges with foods and drugs; data from a highly-specialized single-center study; the involvement of LELP1 gene polymorphisms in atopic dermatitis development; temperature controlled laminar airflow (TLA) benefits children and adolescents with severe eczema and multisystem allergic disease - open label pilot study; primary sensitization versus co-sensitization to hydrolyzed wheat protein; skin symptoms in reported drug hypersensitivity reactions in children; multiple drug hypersensitivity is not infrequent in combination therapy; autoantibody quantity and affinity analysis in chronic autoimmune urticaria patients; omalizumab facilitates cessation of immunosuppressant in severe chronic spontaneous urticaria; urticaria control test (UCT) - responsiveness and minimal important difference; cutaneous lupus as a differential diagnosis in chronic urticaria: a case report; the efficacy of allergen specific immunotherapy in atopic dermatitis patients; mycosis fungoides - the importance of a prolonged follow-up; systemic allergic contact dermatitis from nickel still exists in Europe!; patch testing update: the latest changes in the European baselines series; and identification of potent allergens in 104 skin biopsies from allergic tattoo reactions.
EAACI/ESCD Skin Allergy Meeting 2017 (SAM 2017). (2017). Clinical and Translational Allergy, 7(S4). https://doi.org/10.1186/s13601-017-0184-5